 BEDMER, N.J.--BUSINESS WIRE--- TYME--Tyme Technologies, Inc. NASDAQ: TYME, an emerging biotechnology company developing cancer metabolism-based therapies CMBTsTM, announced financial and operating results for its third quarter ended December 31, 2020. During the quarter, TYME continued to build its leadership team with the announcement of Richie Cunningham as the new CEO; the Company continued to grow its global patent portfolio; expanded its body of peer-reviewed data presentations on SM-88 